Alfresa Holdings Corp.

Pharmaceuticals
Japan
Executive 1Kunio Fukujin, Honorary Chairman; | Honorary Chairman;
Executive 2Denroku Ishiguro, President; | Executive Vice President; Chief Financial Officer;
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$19,554
Current Liabilities (US$ Millions)$7,242
Total Assets (US$ Millions)$7,939
Long Term Debt (Millions)$5
Return on Equity9.94%
Revenue (US$ Millions)$20,991
Total Company Assets$9,802
Revenue Growth (%)4.90%
Net Income (US$ Millions)$214
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$2,324
Profit Margin (%)1.02%
Debt To Equity Ratio (%)0.00%
Inventories (Millions)$1,097